Formidable Asset Management’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-15,175
Closed -$13K 312
2023
Q2
$13K Hold
15,175
﹤0.01% 285
2023
Q1
$11K Buy
15,175
+2,400
+19% +$1.95K ﹤0.01% 309
2022
Q4
$10K Buy
12,775
+1,100
+9% +$1.08K ﹤0.01% 314
2022
Q3
$13K Sell
11,675
-550
-4% -$879 ﹤0.01% 302
2022
Q2
$25K Buy
12,225
+1,075
+10% +$2.23K 0.01% 302
2022
Q1
$33K Buy
+11,150
New +$39.1K 0.01% 338

Formidable Asset Management's SURF Position: Q3 2023 in Review

Formidable Asset Management sold out of Surface Oncology, Inc. Common Stock (SURF) in Q3 2023, closing a stake of 15,175 shares — an estimated $13K sold.

Formidable Asset Management first reported a position in SURF in Q1 2022 and held it in 6 quarters. The position peaked at $33K in Q1 2022. 0 funds tracked by Wall St. Rank hold SURF as of Q3 2023.

  • Formidable Asset Management reported no remaining Surface Oncology, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Formidable Asset Management sold 15,175 Surface Oncology, Inc. Common Stock shares in Q3 2023, an estimated $13K.
  • Formidable Asset Management first reported a position in Surface Oncology, Inc. Common Stock in Q1 2022 and held it in 6 quarters.
  • Formidable Asset Management's Surface Oncology, Inc. Common Stock position peaked at $33K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q3 2023.

Based on Formidable Asset Management's 13F filing for Q3 2023, filed 9 Nov 2023.